Literature DB >> 19141869

Tsc10p and FVT1: topologically distinct short-chain reductases required for long-chain base synthesis in yeast and mammals.

Sita D Gupta1, Kenneth Gable, Gongshe Han, Anna Borovitskaya, Luke Selby, Teresa M Dunn, Jeffrey M Harmon.   

Abstract

In yeast, Tsc10p catalyzes reduction of 3-ketosphinganine to dihydrosphingosine. In mammals, it has been proposed that this reaction is catalyzed by FVT1, which despite limited homology and a different predicted topology, can replace Tsc10p in yeast. Silencing of FVT1 revealed a direct correlation between FVT1 levels and reductase activity, showing that FVT1 is the principal 3-ketosphinganine reductase in mammalian cells. Localization and topology studies identified an N-terminal membrane-spanning domain in FVT1 (absent in Tsc10p) oriented to place it in the endoplasmic reticulum (ER) lumen. In contrast, protease digestion studies showed that the N terminus of Tsc10p is cytoplasmic. Fusion of the N-terminal domain of FVT1 to green fluorescent protein directed the fusion protein to the ER, demonstrating that it is sufficient for targeting. Although both proteins have two predicted transmembrane domains C-terminal to a cytoplasmic catalytic domain, neither had an identifiable lumenal loop. Nevertheless, both Tsc10p and the residual fragment of FVT1 produced by removal of the N-terminal domain with factor Xa protease behave as integral membrane proteins. In addition to their topological differences, mutation of conserved catalytic residues had different effects on the activities of the two enzymes. Thus, while FVT1 can replace Tsc10p in yeast, there are substantial differences between the two enzymes that may be important for regulation of sphingolipid biosynthesis in higher eukaryotes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141869      PMCID: PMC2724050          DOI: 10.1194/jlr.M800580-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  27 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

2.  The HMMTOP transmembrane topology prediction server.

Authors:  G E Tusnády; I Simon
Journal:  Bioinformatics       Date:  2001-09       Impact factor: 6.937

Review 3.  De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway.

Authors:  Alfred H Merrill
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

4.  The PredictProtein server.

Authors:  Burkhard Rost; Guy Yachdav; Jinfeng Liu
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

5.  Topological and mutational analysis of Saccharomyces cerevisiae Ste14p, founding member of the isoprenylcysteine carboxyl methyltransferase family.

Authors:  J D Romano; S Michaelis
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

Review 6.  Organization and functions of sphingolipid biosynthesis in yeast.

Authors:  H Riezman
Journal:  Biochem Soc Trans       Date:  2006-06       Impact factor: 5.407

7.  Critical residues for structure and catalysis in short-chain dehydrogenases/reductases.

Authors:  Charlotta Filling; Kurt D Berndt; Jordi Benach; Stefan Knapp; Tim Prozorovski; Erik Nordling; Rudolf Ladenstein; Hans Jörnvall; Udo Oppermann
Journal:  J Biol Chem       Date:  2002-04-25       Impact factor: 5.157

Review 8.  Short-chain dehydrogenases/reductases (SDR): the 2002 update.

Authors:  Udo Oppermann; Charlotta Filling; Malin Hult; Naeem Shafqat; Xiaoqiu Wu; Monica Lindh; Jawed Shafqat; Erik Nordling; Yvonne Kallberg; Bengt Persson; Hans Jörnvall
Journal:  Chem Biol Interact       Date:  2003-02-01       Impact factor: 5.192

9.  Membrane topology of human insig-1, a protein regulator of lipid synthesis.

Authors:  Jamison D Feramisco; Joseph L Goldstein; Michael S Brown
Journal:  J Biol Chem       Date:  2003-12-05       Impact factor: 5.157

10.  Crystal structure of human L-xylulose reductase holoenzyme: probing the role of Asn107 with site-directed mutagenesis.

Authors:  Ossama El-Kabbani; Shuhei Ishikura; Connie Darmanin; Vincenzo Carbone; Roland P-T Chung; Noriyuki Usami; Akira Hara
Journal:  Proteins       Date:  2004-05-15
View more
  9 in total

1.  A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity.

Authors:  Kenneth Gable; Sita D Gupta; Gongshe Han; Somashekarappa Niranjanakumari; Jeffrey M Harmon; Teresa M Dunn
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

Review 2.  Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.

Authors:  Kenneth C Loh; Dianna Baldwin; Julie D Saba
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

3.  Sphingolipids in the root play an important role in regulating the leaf ionome in Arabidopsis thaliana.

Authors:  Dai-Yin Chao; Kenneth Gable; Ming Chen; Ivan Baxter; Charles R Dietrich; Edgar B Cahoon; Mary Lou Guerinot; Brett Lahner; Shiyou Lü; Jonathan E Markham; Joe Morrissey; Gongshe Han; Sita D Gupta; Jeffrey M Harmon; Jan G Jaworski; Teresa M Dunn; David E Salt
Journal:  Plant Cell       Date:  2011-03-18       Impact factor: 11.277

4.  1,2,4-Triazolidine-3-thiones Have Specific Activity against Acinetobacter baumannii among Common Nosocomial Pathogens.

Authors:  Brendan W Corey; Mitchell G Thompson; Lauren E Hittle; Anna C Jacobs; Edward A Asafo-Adjei; William M Huggins; Roberta J Melander; Christian Melander; Robert K Ernst; Daniel V Zurawski
Journal:  ACS Infect Dis       Date:  2016-11-03       Impact factor: 5.084

5.  Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.

Authors:  Lynn M Boyden; Nicholas G Vincent; Jing Zhou; Ronghua Hu; Brittany G Craiglow; Susan J Bayliss; Ilana S Rosman; Anne W Lucky; Luis A Diaz; Lowell A Goldsmith; Amy S Paller; Richard P Lifton; Susan J Baserga; Keith A Choate
Journal:  Am J Hum Genet       Date:  2017-06-01       Impact factor: 11.025

6.  Regulated targeting of the monotopic hairpin membrane protein Erg1 requires the GET pathway.

Authors:  Ákos Farkas; Henning Urlaub; Katherine E Bohnsack; Blanche Schwappach
Journal:  J Cell Biol       Date:  2022-05-19       Impact factor: 8.077

Review 7.  Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies.

Authors:  Caroline Mota Fernandes; Maurizio Del Poeta
Journal:  Expert Rev Anti Infect Ther       Date:  2020-07-16       Impact factor: 5.091

8.  Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia.

Authors:  Tadbir K Bariana; Veerle Labarque; Jessica Heremans; Chantal Thys; Mara De Reys; Daniel Greene; Benjamin Jenkins; Luigi Grassi; Denis Seyres; Frances Burden; Deborah Whitehorn; Olga Shamardina; Sofia Papadia; Keith Gomez; Nihr BioResource; Chris Van Geet; Albert Koulman; Willem H Ouwehand; Cedric Ghevaert; Mattia Frontini; Ernest Turro; Kathleen Freson
Journal:  Haematologica       Date:  2018-11-22       Impact factor: 9.941

Review 9.  Sphingolipid biosynthesis in man and microbes.

Authors:  Peter J Harrison; Teresa M Dunn; Dominic J Campopiano
Journal:  Nat Prod Rep       Date:  2018-09-19       Impact factor: 13.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.